BMI1 Inhibition Improves Lesion Burden in Cerebral Cavernous Malformations
- PMID: 39186529
- DOI: 10.1161/CIRCULATIONAHA.123.067438
BMI1 Inhibition Improves Lesion Burden in Cerebral Cavernous Malformations
Keywords: cerebral cavernous malformations; endothelium drug therapy; polycomb repressive complexes.
Conflict of interest statement
M.P. is a member of the board of directors and a stakeholder of CheckmAb s.r.l. and is a recipient of a grant under a research agreement with Bristol-Myers Squibb. The other authors report no conflicts.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
